Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1×1 Conference
WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Freshly Unveiled Brand Adds Gaming Industry Veteran Andrew Gore To The Organization London, United Kingdom–(Newsfile…
Toronto, Ontario–(Newsfile Corp. – May 31, 2022) – Xigem Technologies Corporation (CSE: XIGM) (FSE: 2C1)…
DOVER, DE, May 31, 2022 – (ACN Newswire) – Pacific Green Technologies, Inc. (the “Company”…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of preliminary ratings to 17 classes…
Further demonstrates industry leadership position in delivering EML laser chips with superior quality and incident…
Technology leader showcases new innovative solutions for the pro audio industry WOODSTOCK, Ill.–(BUSINESS WIRE)–OWC®, a…
Tiller’s personal finance service now offers a full suite of tools for customers to manage…
John to share unique goal-setting and achievement strategies, followed by keynotes from General Motors, Boston…
LOS ANGELES–(BUSINESS WIRE)–$STOCKS—The Law Offices of Frank R. Cruz announces that a class action lawsuit…
Across the United States and Europe, supercomputing centers depend on wafer-scale solutions from Cerebras for…
Earns 15 top rankings and 33 leading positions in four peer groups in The Planning…
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
Qumulo enables extreme scalability and performance for life sciences organizations managing data-intensive innovations SEATTLE–(BUSINESS WIRE)–Qumulo,…
ISS notes the JetBlue offer is superior from a financial standpoint and that JetBlue offer…
Oral Presentation Delivered at DDW 2022 Informs Clinical Study Design for Biora’s Targeted Therapeutics Platform…
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
–Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as…
London, United Kingdom, May 31, 2022 (GLOBE NEWSWIRE) — Virax Biolabs Group Limited (“Virax” or…